Fundraising Fox
AlphaRose Therapeutics
2 known investors
Find your way into AlphaRose Therapeutics
Sign up to see every warm intro you have to AlphaRose Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AlphaRose Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AlphaRose develops genetic technologies and treatments for children with rare genetic diseases, aiming to make and commercialize such medicines at scale. It targets patients underserved by the current healthcare model for rare genetic conditions.
Investors · 2
Frequently asked questions
- What does AlphaRose Therapeutics do?
- AlphaRose develops genetic technologies and treatments for children with rare genetic diseases, aiming to make and commercialize such medicines at scale. It targets patients underserved by the current healthcare model for rare genetic conditions.
- Who are AlphaRose Therapeutics's investors?
- AlphaRose Therapeutics's investors include Advent Life Sciences, Suncoast Ventures.